Intracoronary Administration of OmniMSC-AMI for Acute ST-segment Elevation Myocardial Infarction Patients
Clinical trial NCT05724576 · TERMINATED
Trial details
- NCT number
- NCT05724576
- Sponsor
- Taiwan Bio Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-26
- Primary completion
- 2026-05-18
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.